Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
about
Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974Pharmacological evaluation of Bioactive Principle of Turnera aphrodisiacaThe tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentinFavorable results from the use of herbal and plant products in inflammatory bowel disease: evidence from experimental animal studiesNatural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewA Decade of Molecular Understanding of Withanolide Biosynthesis and In vitro Studies in Withania somnifera (L.) Dunal: Prospects and Perspectives for Pathway EngineeringSelective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signalingDifferential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidencesNADPH-cytochrome P450 reductase: molecular cloning and functional characterization of two paralogs from Withania somnifera (L.) dunalβ-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide AFunctional and Morphological Correlates in the Drosophila LRRK2 loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) AdministrationDietary and botanical anxiolytics.Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS.Characterization of Withania somnifera leaf transcriptome and expression analysis of pathogenesis-related genes during salicylic acid signaling.Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.Protection of swimming-induced oxidative stress in some vital organs by the treatment of composite extract of Withania somnifera, Ocimum sanctum and Zingiber officinalis in male rat.Anti-stress activity of hydro-alcoholic extract of Eugenia caryophyllus buds (clove).Withania somnifera targets interleukin-8 and cyclooxygenase-2 in human prostate cancer progression.Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin AMammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cellsRectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced inflammatory bowel diseaseWithania somnifera root extract extends lifespan of Caenorhabditis elegans.Medicinal Plants and Other Living Organisms with Antitumor Potential against Lung CancerNon-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin AWithaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.Withanolides-induced breast cancer cell death is correlated with their ability to inhibit heat protein 90Withaferin A induces proteasome inhibition, endoplasmic reticulum stress, the heat shock response and acquisition of thermotolerance.Evaluation of antioxidant potential of Rasayana drugs in healthy human volunteers.Targeting Notch Signaling in Colorectal Cancer.An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera).Antimicrobial activity and probable mechanisms of action of medicinal plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatusWithaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cellsWater extract of ashwagandha leaves limits proliferation and migration, and induces differentiation in glioma cellsAshwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND).Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis.An advocacy for Vaidya-Scientists in Ayurvedic research.
P2860
Q21143741-C64720E1-2CAE-4793-8764-717ECD417775Q24620472-72044CDE-ACE4-4CE3-B3DB-17CAB863C4CAQ24633116-A824FA21-4D0B-4BD0-8698-AB20640650CAQ26745772-32494999-A2A3-479B-85E5-465163CBC230Q26770401-D0BC05B7-74F8-4925-AF99-53D99FEE0CCEQ26774118-B406C831-3F1A-4D30-BBC6-70B8733AB39CQ28475888-9F4D6DBD-0DCB-452B-8E0E-551EFF1F6FB9Q28483352-D42F6E82-2291-488F-A000-629968EF53BCQ28486400-32D7D098-23CA-4E69-9C0A-3844251CA4D3Q28545117-1ACFD469-FCBE-4351-A0C1-05D35848BE37Q28551962-09606873-C96B-4EA9-A331-141EA2E52CBFQ30455278-FC4B937E-C548-4E1D-9234-44E996B9F4BBQ30835468-167C4567-BEE4-473F-814E-8FE40BCF510BQ31158688-D5BF338B-BA47-4741-A28E-E98B3121886FQ33563815-DD6F1DAF-6047-4CD8-B874-4908FE163B13Q33586011-72A753DF-85DD-40BC-9EB6-BE24C62C527AQ33630185-B26002E9-20D1-4EB3-B27A-96CD024E417CQ33671229-D5CD2C77-390E-48AD-90C6-5640F79C8021Q33739134-2CF884F6-26F9-4337-B30E-694F33F1FCC3Q33766685-677BEF15-CCFD-45B6-AD7D-352795A8FBB5Q33766743-A5ED5138-7AB2-42A0-B895-9FBED87963A5Q33826976-046EF792-A39E-4B63-8CD2-D34CD7611F1AQ33853018-80D0F274-9187-499A-B03C-E872E0D86BE8Q33884074-8B196CB3-1894-4C17-9A6F-7C5BEDBA3A95Q33979803-50F26526-C378-4EE4-BBAC-220665B45CC9Q34039548-4C6EE276-F1D6-42FC-8985-E7BBE1B8CCB2Q34175625-203DE2B2-9AA6-4955-82AB-96548B130575Q34253370-47A6CC7E-9970-48E0-A652-E48D52F12A25Q34305025-276D424A-0163-4000-B54F-F2D4978536B0Q34316709-74A6DC15-A76A-402A-9929-9752508EE0A0Q34425281-F11DC73B-0945-4165-A4ED-8FCA45F779F8Q34482399-3168FA62-4332-4335-8489-0CA1E1B44D85Q34729658-ECAFF774-0856-41F3-AEBD-4B53DC359C66Q34778747-323C5381-5F2C-4801-A22A-A87CCF916D82Q34828174-8E4874FA-8DB5-4D2B-8B32-2A97143CBAB7Q34878214-53CCE0EF-0619-4346-9E93-DBD5AC2E5220Q34987033-DEB25B2C-A7E8-4967-8C65-50298D5E3E0BQ35023273-81EFF977-13BC-4E96-BC3C-558726F2C366Q35064952-A213278B-B009-4B65-A56F-26F087527BFEQ35145137-CC13C04D-C341-4022-835A-69F1FF7E40F4
P2860
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
@ast
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
@en
Scientific basis for the therapeutic use of Withania somnifera
@nl
type
label
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
@ast
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
@en
Scientific basis for the therapeutic use of Withania somnifera
@nl
prefLabel
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
@ast
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
@en
Scientific basis for the therapeutic use of Withania somnifera
@nl
P2093
P1476
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
@en
P2093
P304
P577
2000-08-01T00:00:00Z